Background illustration for clinical trials search

Paid Clinical Trials Baltimore

Discover 2,405 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

for
Metastatic Melanoma, Advanced Locoregional Melanoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05155033

Phase 2, Recruiting

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

for
HIV-1
Location: Baltimore MD, The Bronx NY, Jacksonville FL, Houston TX,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 0

Code: NCT06517693

Phase 1, Recruiting

A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders

for
Sleep Disorder
Location: Baltimore MD, Towson MD
Sponsor: Itamar-Medical, Israel

Sex: All

Age: 12 - 70+

Code: NCT06093633

Recruiting

A Retrospective Study to Characterize Participants With Propionic Acidemia

for
Propionic Acidemia
Location: Baltimore MD, Philadelphia PA, Seattle WA
Sponsor: ModernaTX, Inc.

Sex: All

Age: 2+

Code: NCT05769621

Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

for
Chronic Obstructive Pulmonary Disease (COPD), Allergies
Location: Baltimore MD, Philadelphia PA, New York NY,
Sponsor: Johns Hopkins University

Sex: All

Age: 40+

Code: NCT07059091

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Genomic Predictors of Recurrent Pregnancy Loss

for
Recurrent Pregnancy Loss
Location: Baltimore MD, Hershey PA, New York NY, New Haven CT,
Sponsor: Yale University

Sex: All

Age: 18 - 50

Code: NCT05444283

Recruiting

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

for
Immunodeficiency, Hematopoietic Stem Cell Transplantation
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05027945

Phase 2, Recruiting

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

for
HIV
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT00029445

Recruiting

Improving Information Sharing Between Family Caregivers and Home Care Aides

for
Shared Care
Location: Baltimore MD
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: All

Age: 18+

Code: NCT07227558

Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Bethesda MD, Charlottesville VA, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase 3, Recruiting

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

for
Somatostatin Receptor Positive,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06427798

Phase 1, Phase 2, Recruiting

Resolution of Comorbidities & Safety and Efficacy of Greater Curvature Plication in Obese Patients

for
Morbid Obesity
Location: Baltimore MD
Sponsor: Singh, Kuldeep, M.D., P.A.

Sex: All

Age: 18 - 65

Code: NCT02315105

Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Baltimore MD, Wilmington DE, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 6 - 39

Code: NCT05702645

Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for
Bladder Cancer
Location: Baltimore MD, Washington D.C. DC, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07419295

Phase 3, Recruiting

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

for
Hepatitis C
Location: Baltimore MD, The Bronx NY, Stony Brook NY, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: Female

Age: 16 - 45

Code: NCT07040319

Phase 1, Phase 2, Recruiting

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

for
Coronary Artery Disease
Location: Baltimore MD
Sponsor: LifeBridge Health

Sex: All

Age: 18+

Code: NCT00370045

Recruiting

White Matter Plasticity in Schizophrenia

for
Schizophrenia Disorders
Location: Catonsville MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 15 - 45

Code: NCT06641297

Recruiting

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Baltimore MD, Indianapolis IN, Birmingham AL,
Sponsor: Naga P. Chalasani

Sex: All

Age: 18+

Code: NCT07143968

Phase 2, Recruiting

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

for
Posterior Fossa Ependymal Tumor
Location: Baltimore MD, Washington D.C. DC, Durham NC,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 39

Code: NCT07226453

Phase 2, Recruiting

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

for
Small Cell Lung Cancer
Location: Baltimore MD, York PA, Chapel Hill NC, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05257551

Recruiting